Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis.

Cheng, Ji; Shuai, Xiaoming; Gao, Jinbo; Wang, Guobin; Tao, Kaixiong; Cai, Kailin

Cheng, Ji; Shuai, Xiaoming; Gao, Jinbo; Wang, Guobin; Tao, Kaixiong; Cai, Kailin.

Afiliação

Cheng J; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277 Jiefang Avenue, Wuhan 430022, China.
Shuai X; Department of Gastrointestinal Surgery, Huazhong University of Science and Technology, Wuhan, China.
Gao J; Department of Gastrointestinal Surgery, Huazhong University of Science and Technology, Wuhan, China.
Wang G; Department of Gastrointestinal Surgery, Huazhong University of Science and Technology, Wuhan, China.
Tao K; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cai K; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.

Ther Adv Med Oncol ; 12: 1758835920974195, 2020.

Article em En | MEDLINE | ID: mdl-33403014

Palavras-chave

3-month capecitabine plus oxaliplatin; adjuvant treatment; network meta-analysis; resectable colon cancer; systematic review

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google